source
- Big Pharma execs urge biotech firms to be transparent and patient to win dealsAt Fierce Biotech's London Life Sciences Week, representatives from five major pharmaceutical companies shared how they evaluate biotech partners. Bayer's head of business development warned that…
- Biogen's low-dose tau drug shows greater slowing of Alzheimer’s progression after two yearsBiogen reported new data on its experimental tau-reducing therapy diranersen, showing that the lowest dose continued to slow Alzheimer’s disease progression after nearly two years of treatment. Th…